Overview
Laurent Quero practices in Paris, France. Mr. Quero is rated as an Experienced expert by MediFind in the treatment of Cyclic Neutropenia. His top areas of expertise are Anal Cancer, Kaposi Sarcoma, Esophageal Cancer, Mastectomy, and Orchiectomy.
His clinical research consists of co-authoring 99 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cyclic Neutropenia.
Locations
Poitiers, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerMr. Quero isDistinguished. Learn about Anal Cancer.
- Advanced
- Colorectal CancerMr. Quero isAdvanced. Learn about Colorectal Cancer.
- Esophageal CancerMr. Quero isAdvanced. Learn about Esophageal Cancer.
- Kaposi SarcomaMr. Quero isAdvanced. Learn about Kaposi Sarcoma.
- Experienced
- Adult Soft Tissue SarcomaMr. Quero isExperienced. Learn about Adult Soft Tissue Sarcoma.
- B-Cell LymphomaMr. Quero isExperienced. Learn about B-Cell Lymphoma.
- Basal Cell Skin CancerMr. Quero isExperienced. Learn about Basal Cell Skin Cancer.
- Bone TumorMr. Quero isExperienced. Learn about Bone Tumor.
- Breast CancerMr. Quero isExperienced. Learn about Breast Cancer.
- Chronic Familial NeutropeniaMr. Quero isExperienced. Learn about Chronic Familial Neutropenia.